An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies

An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies

Saved in:
Bibliographic Details
Main Authors: Alison Findlay, Craig Turner, Heidi Schilter, Mandar Deodhar, Wenbin Zhou, Lara Perryman, Jonathan Foot, Amna Zahoor, Yimin Yao, Ross Hamilton, Mary Brock, Christina Raso, Jessica Stolp, Marie Galati, Dieter Hamprecht, Brett Charlton, Wolfgang Jarolimek
Format: article
Language:EN
Published: Wiley 2021
Subjects:
Medicine (General)
R5-920
Online Access:https://doaj.org/article/c99b1b5618214a2193bedd33dab46b7d
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c99b1b5618214a2193bedd33dab46b7d

Similar Items